5,7-Diiodo-8-Quinolinol - CAS 83-73-8
Catalog number: 83-73-8
Category: Inhibitor
Please be kindly noted products are not for therapeutic use. We do not sell to patients.
Molecular Formula:
C9H5NOI2
Molecular Weight:
396.95
COA:
Inquire
Targets:
Others
Description:
5,7-Diiodo-8-Quinolinol is a topical therapeutic agent with satisfactory antibacterial properties. It is poorly absorbed from the gastrointestinal tract and is used as a luminal amebicide. It acts by chelation of ferrous ions essential for metabolism. It is active against both cyst and trophozoites that are localized in the lumen of the intestine. It is used in the treatment of amoebiasis. It is considered the drug of choice for treating asymptomatic or moderate forms of amebiasis. It was discovered by Adco Co.
Purity:
98%
Appearance:
Yellow to Tan Powder or Crystals
Synonyms:
Iodoquinol;5,7-diiodoquinolin-8-ol;5,7-Diiodo-8-hydroxyquinoline;Diiodohydroxyquinoline;Diiodohydroxyquinoline
Solubility:
10 mM in DMSO
Storage:
-20°C Freezer
MSDS:
Inquire
Application:
5,7-Diiodo-8-Quinolinol is active against both cyst and trophozoites that are localized in the lumen of the intestine. It is used in the treatment of amoebiasis. It is considered the drug of choice for treating asymptomatic or moderate forms of amebiasis.
Quality Standard:
USP standard
Shelf Life:
2 month in rt, long time
Quantity:
Kilogram to ton
Boiling Point:
401.8±45.0 °C | Condition: Press: 760 Torr
Melting Point:
210 °C
Density:
2.491±0.06 g/cm3 | Condition: Temp: 20 °C Press: 760 Torr
InChIKey:
UXZFQZANDVDGMM-UHFFFAOYSA-N
InChI:
InChI=1S/C9H5I2NO/c10-6-4-7(11)9(13)8-5(6)2-1-3-12-8/h1-4,13H
Canonical SMILES:
C1=CC2=C(C(=C(C=C2I)I)O)N=C1
Current Developer:
5,7-Diiodo-8-Quinolinol was discovered by Adco Co.
1.Oral treatment of acrodermatitis enteropathica with zinc sulfate.
Der Kaloustian VM;Musallam SS;Sanjad SA;Murib A;Hammad WD;Idriss ZH Am J Dis Child. 1976 Apr;130(4):421-3.
In a 7-year-old boy with acrodermatitis enteropathica, oral administration of zinc sulfate brought about complete relief of symptoms and signs, with clearing of the skin lesions, arrest of diarrhea, and growth of new hair. Considering the dramatic results obtained, we believe that oral treatment with zinc sulfate is an innocuous, inexpensive, and very effective medication for acrodermatitis enteropathica, which can replace the previously used and toxic diiodohydroxyquin-like drugs.
2.Treatment of acrodermatitis enteropathica with zinc sulfate.
Campo AG Jr;McDonald CJ Arch Dermatol. 1976 May;112(5):687-9.
Control of a case of acrodermatitis enteropathica was achieved initially after three months of treatment with diiodohydroxyquin (Diodoquin). Reexacerbation of acrodermatitis enteropathica was noted two months after diiodohydroxyquin was discontinued. Treatment with zinc sulfate was substituted and resulted in dramatic and complete resolution of disease within 48 hours.
3.A review of the clinical presentation of dientamoebiasis.
Stark D;Barratt J;Roberts T;Marriott D;Harkness J;Ellis J Am J Trop Med Hyg. 2010 Apr;82(4):614-9. doi: 10.4269/ajtmh.2010.09-0478.
Among 750 symptomatic and asymptomatic patients, Dientamoeba fragilis was detected at a prevalence of 5.2% and more common than Giardia intestinalis. Most infected patients presented with diarrhea and abdominal pain with symptoms greater than 2 weeks duration being common. Bacterial and viral causes of infection were excluded by routine microbiological techniques. Treatment of D. fragilis infection with either iodoquinol, paromomycin, or combination therapy resulted in the eradication of the parasite and complete resolution of symptoms. Treatment failure/relapses were associated only with the use of metronidazole. Nineteen patients were examined for pin worm, no Enterobius vermicularis, a proposed vector of transmission, were detected. Intermittent shedding of D. fragilis was found to be highly variable. These studies confirm the pathogenic nature of D. fragilis and we recommend laboratories routinely test for the organism.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related Products


CAS 58749-22-7 Licochalcone A

Licochalcone A
(CAS: 58749-22-7)

Licochalcone A is an estrogenic flavanoid extracted from licorice root, showing antimalarial, anticancer, antibacterial and antiviral activities. Phase 3.

HLCL65 hydrochloride

HLCL65 hydrochloride is a first-in-class inhibitor of PRMT5. HLCL65 selectively inhibits Th1 cell proliferation (IC50 value 1.1 μM). In vivo, HLCL65 suppresses ...

CAS 47141-42-4 Levobunolol

Levobunolol
(CAS: 47141-42-4)

Levobunolol is a nonselective beta-adrenoceptor antagonist used in the treatment of glaucoma.

CAS 1114544-31-8 Ponatinib hydrochloride

Ponatinib hydrochloride
(CAS: 1114544-31-8)

Ponatinib hydrochloride is an oral drug for the treatment of chronic myeloid leukemia (CML) and Philadelphia chromosome–positive (Ph+) acute lymphoblastic leuke...

CAS 50-01-1 Guanidine Hydrochloride

Guanidine Hydrochloride
(CAS: 50-01-1)

Guanidine HCl, the crystalline compound of strong alkalinity formed by the oxidation of guanine, is a normal product of protein metabolism and a protein denatur...

CAS 88531-67-3 LH secretion antagonist 1

LH secretion antagonist 1
(CAS: 88531-67-3)

An antagonist of luteinising hormone secretion

CAS 103-16-2 Monobenzone

Monobenzone
(CAS: 103-16-2)

Monobenzone is a compound used as a topical agent for medical depigmentation.The topical application of monobenzone in animals decreases the excretion of melani...

CAS 149845-07-8 Tiludronic acid disodium salt

Tiludronic acid disodium salt
(CAS: 149845-07-8)

The disodium salt form of Tiludronic acid which has been found to be a biphosphonate bone resorption inhibitor and could be used against osteitis deformans.

Chemical Structure

CAS 83-73-8 5,7-Diiodo-8-Quinolinol

Quick Inquiry

Verification code

Featured Items